AI-Guided Left Bundle Branch Area Pacing
Recruiting now · Not applicable
Conditions studied: Heart Failure
In brief
The purpose of this study is to compare the effectiveness of AI-guided LBBAP versus conventional LBBAP (not AI-guided) in improving CRT response rates and clinical outcomes.
Key facts
- Study ID
- NCT07206602
- Run by
- Mayo Clinic
- People needed
- 224
- Starts
- 2026-01-23
- Expected to finish
- 2027-11-01
- Last updated by the study team
- 2026-02-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age: 18 years or older.
- Left Ventricular Ejection Fraction (LVEF): <50% within 6 months prior to enrollment.
- QRS Duration: Resting QRS duration ≥ 130 ms on ECG OR anticipated right ventricular pacing > 40% OR device in place with right ventricular pacing > 40% within 6 months prior to enrollment.
- Medical Therapy: Optimized on guideline-directed medical therapy for heart failure.
- AI-ECG probability of low LVEF: >0.5
You may not qualify if…
- Age less than 18 years old
- Inability to follow-up
- Pregnancy
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.